Cargando…

HIV-1 Latency and Viral Reservoirs: Existing Reversal Approaches and Potential Technologies, Targets, and Pathways Involved in HIV Latency Studies

Eradication of latent human immunodeficiency virus (HIV) infection is a global health challenge. Reactivation of HIV latency and killing of virus-infected cells, the so-called “kick and kill” or “shock and kill” approaches, are a popular strategy for HIV cure. While antiretroviral therapy (ART) halt...

Descripción completa

Detalles Bibliográficos
Autores principales:	Khanal, Sushant, Schank, Madison, El Gazzar, Mohamed, Moorman, Jonathan P., Yao, Zhi Q.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7926981/ https://www.ncbi.nlm.nih.gov/pubmed/33672138 http://dx.doi.org/10.3390/cells10020475

Ejemplares similares

HIV interactions with monocytes and dendritic cells: viral latency and reservoirs
por: Coleman, Christopher M, et al.
Publicado: (2009)

HIV-1 Latency and Latency Reversal: Does Subtype Matter?
por: Sarabia, Indra, et al.
Publicado: (2019)

Anti-latency agents to purge HIV reservoirs
por: Moreno, Santiago
Publicado: (2012)

Latency reversal plus natural killer cells diminish HIV reservoir in vivo
por: Kim, Jocelyn T., et al.
Publicado: (2022)

Human Immunodeficiency Virus 1 (HIV-1): Viral Latency, the Reservoir, and the Cure
por: Ventura, John D.
Publicado: (2020)

New Concepts in Therapeutic Manipulation of HIV-1 Transcription and Latency: Latency Reversal versus Latency Prevention
por: Lewis, Catherine A., et al.
Publicado: (2023)

The role of latency reversal in HIV cure strategies
por: Tanaka, Kiho, et al.
Publicado: (2022)

Current Status of Latency Reversing Agents Facing the Heterogeneity of HIV-1 Cellular and Tissue Reservoirs
por: Ait-Ammar, Amina, et al.
Publicado: (2020)

Tracking HIV Rebound following Latency Reversal Using Barcoded HIV
por: Marsden, Matthew D., et al.
Publicado: (2020)

Bioinformatics and HIV Latency
por: Ciuffi, Angela, et al.
Publicado: (2015)

The Depsipeptide Romidepsin Reverses HIV-1 Latency In Vivo
por: Søgaard, Ole S., et al.
Publicado: (2015)

Elimination of HIV-1-Infected Primary T Cell Reservoirs in an In Vitro Model of Latency
por: Rawlings, Stephen A., et al.
Publicado: (2015)

Impact of IL-15 and latency reversing agent combinations in the reactivation and NK cell-mediated suppression of the HIV reservoir
por: Covino, Daniela Angela, et al.
Publicado: (2022)

The efficacy and tolerability of latency-reversing agents in reactivating the HIV-1 reservoir in clinical studies: a systematic review
por: Debrabander, Quinten, et al.
Publicado: (2023)

The BAF complex and HIV latency
por: Mahmoudi, Tokameh
Publicado: (2012)

Diverse effects of interferon alpha on the establishment and reversal of HIV latency
por: Van der Sluis, Renée M., et al.
Publicado: (2020)

HIV cure trial mergers: Spotlighting the epigenetics of latency reversal
por: Denton, Paul W.
Publicado: (2022)

NSC95397 is a Novel HIV Latency Reversing Agent
por: Nichols Doyle, Randilea, et al.
Publicado: (2023)

Molecular mechanisms involved in HIV latency and implications for HIV treatment and eradication
por: Alcami, Jose, et al.
Publicado: (2010)

HibeRNAtion: HIV-1 RNA Metabolism and Viral Latency
por: Crespo, Raquel, et al.
Publicado: (2022)

Virally Suppressed People Living with HIV Who Use Opioids Have Diminished Latency Reversal
por: Basukala, Binita, et al.
Publicado: (2023)

Editorial: The relevance of molecular mechanisms in HIV-1 latency and reactivation from latency
por: Pasternak, Alexander O., et al.
Publicado: (2023)

Synthetic gRNA/Cas9 Ribonucleoprotein Inhibits HIV Reactivation and Replication
por: Khanal, Sushant, et al.
Publicado: (2022)

Cellular and molecular mechanisms involved in the establishment of HIV-1 latency
por: Donahue, Daniel A, et al.
Publicado: (2013)

Chromatin, gene silencing and HIV latency
por: Mok, Hoi-Ping, et al.
Publicado: (2007)

Latency: the hidden HIV-1 challenge
por: Marcello, Alessandro
Publicado: (2006)

Molecular Understanding of HIV-1 Latency
por: Abbas, W., et al.
Publicado: (2012)

HIV-1 latency in activated T-cells
por: Berkhout, Ben
Publicado: (2013)

HIV-1 Latency in Monocytes/Macrophages
por: Kumar, Amit, et al.
Publicado: (2014)

HIV-1 transcription and latency: an update
por: Van Lint, Carine, et al.
Publicado: (2013)

Insights into the HIV Latency and the Role of Cytokines
por: Hokello, Joseph, et al.
Publicado: (2019)

Dynamics of the Gene Regulatory Network of HIV-1 and the Role of Viral Non-coding RNAs on Latency Reversion
por: Bensussen, Antonio, et al.
Publicado: (2018)

Relevance of multiply spliced HIV-1 RNA measurement in assessing the efficacy of viral latency-reversing strategies
por: Doria, Margherita
Publicado: (2021)

The Effect of JAK1/2 Inhibitors on HIV Reservoir Using Primary Lymphoid Cell Model of HIV Latency
por: de Armas, Lesley R., et al.
Publicado: (2021)

Corrigendum: Editorial: The relevance of molecular mechanisms in HIV-1 latency and reactivation from latency
por: Pasternak, Alexander O., et al.
Publicado: (2023)

Human Immunodeficiency Virus (HIV)-1 Integration Sites in Viral Latency
por: Rezaei, Simin D., et al.
Publicado: (2015)

Combinations of Histone Deacetylase Inhibitors with Distinct Latency Reversing Agents Variably Affect HIV Reactivation and Susceptibility to NK Cell-Mediated Killing of T Cells That Exit Viral Latency
por: Covino, Daniela A., et al.
Publicado: (2021)

The Impact of HIV- and ART-Induced Mitochondrial Dysfunction in Cellular Senescence and Aging
por: Schank, Madison, et al.
Publicado: (2021)

Characterization of designed, synthetically accessible bryostatin analog HIV latency reversing agents
por: Marsden, Matthew D., et al.
Publicado: (2018)

HIV latency reversing agents act through Tat post translational modifications
por: Khoury, Georges, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_apltvlvdg0556huj39oku7rfcj